Verrica Pharmaceuticals
VRCA
53 hedge funds and large institutions have $112M invested in Verrica Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 18 reducing their positions, and 9 closing their positions.
50% more call options, than puts
Call options by funds: $3K | Put options by funds: $2K
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
4% more funds holding
Funds holding: 51 → 53 (+2)
0.01% more ownership
Funds ownership: 3.61% → 3.63% (+0.01%)
25% less capital invested
Capital invested by funds: $150M → $112M (-$38.1M)
39% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 18
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$3.47M |
| 2 |
Morgan Stanley
New York
|
+$1.42M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.13M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$381K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$260K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.03M |
| 2 |
JG
Jefferies Group
New York
|
-$1.7M |
| 3 |
DMK
David M. Knott
|
-$933K |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$672K |
| 5 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$599K |
VRCA Hedge Fund Activity: Q2 2021 in Review
53 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Verrica Pharmaceuticals (VRCA) for Q2 2021, worth a combined $112M — down 25% from $150M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new VRCA positions and 9 closed out — a net gain of 2 holders — while 11 added to existing stakes and 18 trimmed.
The largest buyer was Millennium Management, adding an estimated $3.47M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $3.03M sold.
- 53 institutional investors held Verrica Pharmaceuticals (VRCA) as of Q2 2021, up from 51 in Q1 2021.
- Funds reported $112M of Verrica Pharmaceuticals stock for Q2 2021, down 25% quarter-over-quarter.
- 11 funds opened new Verrica Pharmaceuticals positions in Q2 2021 and 9 closed out, a net change of +2 holders.
- The largest Verrica Pharmaceuticals buyer in Q2 2021 was Millennium Management, an estimated $3.47M added.
- The largest Verrica Pharmaceuticals seller in Q2 2021 was Monashee Investment Management, an estimated $3.03M sold.
Based on aggregated 13F filings for Q2 2021.